More recently, in a large retrospective study of 212 tumor samples, the same Authors (Ino et al., 2013) reported that in multivariate analysis the prevalence of tumor infiltrating CD4+ Thigh/CD8+ Thigh/%Treglow significantly correlated with longer survival and had a higher hazard ratio. This evidence concerns the gene CD8A and neoplasm.